U.S. markets close in 3 hours 52 minutes

Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
3.0200+0.0300 (+1.00%)
At close: 3:00PM CST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.9900
Bid3.0100 x 0
Ask3.0200 x 0
Day's Range2.9300 - 3.0500
52 Week Range2.3800 - 4.3600
Avg. Volume23,961,126
Market Cap7.604B
Beta (5Y Monthly)0.26
PE Ratio (TTM)N/A
EPS (TTM)-0.3190
Earnings DateAug 24, 2021 - Aug 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 04, 2018
1y Target Est22.12
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • U.S. senator asks for CFIUS review of GNC purchase by Chinese company

      U.S. senator asks for CFIUS review of GNC purchase by Chinese company

      U.S. Senator Marco Rubio, a Republican and a China hawk, asked for a national security review of plans by General Nutrition Centers <GNC.N>, or GNC, to sell itself to Harbin Pharmaceutical Group Co Ltd. Rubio, who had also urged a probe of TikTok's ownership by another Chinese firm, made the request in a letter to Treasury Secretary Steven Mnuchin. GNC, a health and nutrition products retailer, has said it has agreed in principle with many lenders to sell itself to an affiliate of its largest shareholder, Harbin Pharmaceutical <600664.SS>, for $760 million in a court-supervised auction, subject to higher bids.